Karmanos Cancer Institute and the Detroit Tigers honor survivors and promote breast health at 10th Annual Pink Out the Park game

Via Peters

Throughout the game and in the Comerica Park concourse, fans will have the opportunity to engage with several activities, including a ceremonial first pitch, in-game awareness promotions, and an on-field recognition ceremony honoring members of the Karmanos Breast Cancer Multidisciplinary Team. Tigers fans will have the opportunity to honor a […]

Nivolumab Plus Trastuzumab Deruxtecan Provides No Perceptible Clinical Benefit Over ADC Alone in Advanced HER2+ Breast Cancer

Via Peters

The addition of nivolumab to trastuzumab deruxtecan did not result in a marked clinical benefit in patients with locally advanced unresectable or metastatic HER2-positive breast cancer. The addition of nivolumab (Opdivo) to fam-trastuzumab deruxtecan-nxki (Enhertu) did not result in a marked clinical benefit in patients with locally advanced unresectable or […]

Vitamin D may reduce risk in Black and Hispanic women

Via Peters

Share on PinterestNew research highlights the importance of healthy vitamin D levels in Black and Hispanic women. gorodenkoff/Getty Images Vitamin D deficiency is increasing and people with dark skin living in the Northern hemisphere are particularly affected. Deficiency is increasingly being linked to various diseases including breast cancer. A study […]

NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of its Topical Investigational Drug in the Treatment of Cutaneous Metastases of Breast Cancer

Via Peters

FORT WORTH, Texas–(BUSINESS WIRE)–NanOlogy LLC, a clinical-stage interventional oncology drug company, announced today that results from a clinical trial of topical submicron particle paclitaxel (SOR007) in cutaneous metastases of breast cancer (CMBOC) have been published in Breast Cancer Research and Treatment. The research article entitled Phase 1/2 Study of Topical […]

TROP2 as patient-tailoring but not prognostic biomarker

Via Peters

Introduction With more than 2.3 million estimated new cases in 2020, breast cancer (BC) is the most commonly diagnosed cancer (~24.5%) and the leading cause of cancer death (~15.5%) in women.1 Clinically, BC can be divided into different subtypes by their histopathological appearance and expression status of the estrogen receptor […]